Anish Bhatnagar
CHIEF EXECUTIVE OFFICER at SOLENO THERAPEUTICS INC
- Sold, on record
- $67.9M
- Dollars the filings state
- Form 4 sales
- 12
- Latest Mar 27, 2025
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- SOLENO THERAPEUTICS INCCHIEF EXECUTIVE OFFICER
Sales by reason
0
Routine
1
Plan not stated
6
No plan
5
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Mar 27, 2025Unusual
Sold 54.8% of their holdings
$47.3M699,095 shares at $67.62
- Mar 27, 2025Notice
Filed a notice to sell 746,041 shares
$37.3M746,041 shares
- Jan 3, 2025No plan
Sold 2.9% of their holdings
$966k21,091 shares at $45.78
- Oct 1, 2024No plan
Sold 2.9% of their holdings
$1.1M21,633 shares at $49.43
- Aug 29, 2024Unusual
Sold 13.4% of their holdings
$5.5M115,004 shares at $47.43
- Aug 6, 2024Unusual
Sold 12.9% of their holdings
$5.8M127,344 shares at $45.60
- Jul 1, 2024No plan
Sold 12.6% of their holdings
$800k19,256 shares at $41.54
- Apr 1, 2024No plan
Sold 11% of their holdings
$785k18,980 shares at $41.34
- Jan 25, 2024No plan
Sold 1.4% of their holdings
$122k2,527 shares at $48.30
- Dec 11, 2023Unusual
Sold 79.4% of their holdings
$3.3M93,408 shares at $35.67
10 of 14
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | May 18, 2026 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Returned to the companyEmployee Stock Option (Right to buy) | 763,112 | 0 | SEC | ||
| May 18, 2026 | May 18, 2026 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Returned to the company | 583,656 | 0 | SEC | ||
| Jan 21, 2026 | Jan 23, 2026 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | AwardedEmployee stock option (right to buy) | 131,400 | 131,400 | SEC | ||
| Jan 21, 2026 | Jan 23, 2026 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Awarded | 114,200 | 583,656 | SEC | ||
| Dec 15, 2025 | Dec 17, 2025 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Gift | 100,000 | 469,456 | SEC | ||
| Dec 15, 2025 | Dec 17, 2025 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Withheld for tax | 7,620 | $49.95 | $381k | 569,456 | SEC |
| Mar 27, 2025 | Mar 31, 2025 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Sold | 699,095 | $67.62 | $47.3M | 577,076 | SEC |
| Mar 27, 2025 | Mar 31, 2025 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Exercised or settledEmployee stock option (right to buy) | 523,809 | 200,753 | SEC | ||
| Mar 27, 2025 | Mar 31, 2025 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Exercised options | 523,809 | $12.17 | $6.4M | 1.1M | SEC |
| Jan 21, 2025 | Jan 23, 2025 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | AwardedEmployee stock option (right to buy) | 115,600 | 115,600 | SEC | ||
| Jan 21, 2025 | Jan 23, 2025 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Awarded | 53,900 | 752,362 | SEC | ||
| Jan 3, 2025 | Jan 6, 2025 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Sold | 21,091 | $45.78 | $966k | 698,462 | SEC |
| Oct 1, 2024 | Oct 3, 2024 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Sold | 21,633 | $49.43 | $1.1M | 719,553 | SEC |
| Aug 29, 2024 | Aug 30, 2024 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Sold | 115,004 | $47.43 | $5.5M | 741,186 | SEC |
| Aug 6, 2024 | Aug 7, 2024 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Sold | 127,344 | $45.60 | $5.8M | 856,190 | SEC |
| Jul 17, 2024 | Jul 19, 2024 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Awarded | 850,000 | 983,534 | SEC | ||
| Jul 1, 2024 | Jul 3, 2024 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Sold | 19,256 | $41.54 | $800k | 133,534 | SEC |
| Apr 1, 2024 | Apr 3, 2024 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Sold | 18,980 | $41.34 | $785k | 152,790 | SEC |
| Jan 25, 2024 | Jan 29, 2024 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Sold | 2,527 | $48.30 | $122k | 171,770 | SEC |
| Jan 4, 2024 | Jan 8, 2024 | SOLENO THERAPEUTICS INC | Chief Executive Officer | AwardedEmployee stock option (right to buy) | 100,000 | 100,000 | SEC | ||
| Jan 4, 2024 | Jan 8, 2024 | SOLENO THERAPEUTICS INC | Chief Executive Officer | Awarded | 150,000 | 174,297 | SEC | ||
| Dec 11, 2023 | Dec 13, 2023 | SOLENO THERAPEUTICS INC | Chief Executive Officer | Sold | 93,408 | $35.67 | $3.3M | 24,297 | SEC |
| Nov 30, 2023 | Dec 4, 2023 | SOLENO THERAPEUTICS INC | Chief Executive Officer | Sold | 27,716 | $28.65 | $794k | 108,062 | SEC |
| Nov 29, 2023 | Nov 30, 2023 | SOLENO THERAPEUTICS INC | Chief Executive Officer | Sold | 53,505 | $27.49 | $1.5M | 135,778 | SEC |
| Oct 20, 2023 | Dec 13, 2023 | SOLENO THERAPEUTICS INC | Chief Executive Officer | Exercised or settledWarrants (right to buy) | 9,643 | $0.26 | $2k | 0 | SEC |
| Oct 20, 2023 | Dec 13, 2023 | SOLENO THERAPEUTICS INC | Chief Executive Officer | Exercised options | 9,643 | $3.16 | $31k | 198,926 | SEC |
| May 26, 2023 | May 26, 2023 | SOLENO THERAPEUTICS INC | Chief Executive Officer | AwardedEmployee stock option (right to buy) | 481,806 | 481,806 | SEC | ||
| May 26, 2023 | May 26, 2023 | SOLENO THERAPEUTICS INC | Chief Executive Officer | Awarded | 160,602 | 189,283 | SEC | ||
| May 8, 2023 | May 10, 2023 | SOLENO THERAPEUTICS INC | Chief Executive Officer | AwardedWarrants (right to buy) | 5,643 | $0.44 | $2k | 3,500 | SEC |
| Jan 25, 2023 | Jan 27, 2023 | SOLENO THERAPEUTICS INC | Chief Executive Officer | AwardedEmployee stock option (right to buy) | 115,000 | 115,000 | SEC | ||
| Jul 27, 2022 | Jul 29, 2022 | SOLENO THERAPEUTICS INC | Chief Executive Officer | AwardedEmployee stock option (right to buy) | 1.1M | 1.1M | SEC | ||
| Mar 31, 2022 | Apr 4, 2022 | SOLENO THERAPEUTICS INC | Chief Executive Officer | BoughtWarrant (right to buy) | 60,000 | 60,000 | SEC | ||
| Mar 31, 2022 | Apr 4, 2022 | SOLENO THERAPEUTICS INC | Chief Executive Officer | Bought | 60,000 | 430,227 | SEC | ||
| Jan 28, 2022 | Feb 1, 2022 | SOLENO THERAPEUTICS INC | Officer, Director | AwardedEmployee stock option (right to buy) | 610,000 | 610,000 | SEC | ||
| Jan 21, 2022 | Jan 25, 2022 | SOLENO THERAPEUTICS INC | Chief Executive Officer | Sold | 39,033 | $0.37 | $14k | 370,227 | SEC |
| Jan 23, 2021 | Jan 26, 2021 | SOLENO THERAPEUTICS INC | Chief Executive Officer | Withheld for tax | 36,318 | $2.11 | $77k | 4.1M | SEC |
| Jan 8, 2021 | Jan 12, 2021 | SOLENO THERAPEUTICS INC | Officer, Director | AwardedEmployee stock option (right to buy) | 2.1M | 4.1M | SEC | ||
| May 18, 2020 | May 20, 2020 | SOLENO THERAPEUTICS INC | Officer, Director | AwardedEmployee stock option (right to buy) | 350,000 | 350,000 | SEC | ||
| Jan 23, 2020 | Jan 24, 2020 | SOLENO THERAPEUTICS INC | Chief Executive Officer | Awarded | 381,000 | $3.35 | $1.3M | 381,000 | SEC |
| Jan 24, 2019 | Jan 28, 2019 | SOLENO THERAPEUTICS INC | President and CEO | AwardedEmployee stock option (right to buy) | 250,000 | 250,000 | SEC | ||
| Feb 7, 2018 | Feb 9, 2018 | SOLENO THERAPEUTICS INC | President and CEO | AwardedEmployee stock option (right to buy) | 500,625 | 100,625 | SEC | ||
| Apr 19, 2017 | Apr 24, 2017 | SOLENO THERAPEUTICS INC | President and CEO | AwardedEmployee stock option (right to buy) | 1.7M | 1.7M | SEC | ||
| Aug 19, 2016 | Aug 22, 2016 | SOLENO THERAPEUTICS INC | Officer, Director | Bought | 10,000 | $0.96 | $10k | 83,419 | SEC |
| Jun 8, 2016 | Jun 10, 2016 | SOLENO THERAPEUTICS INC | Officer, Director | AwardedEmployee stock option (right to buy) | 301,175 | 301,175 | SEC | ||
| May 13, 2016 | May 16, 2016 | SOLENO THERAPEUTICS INC | President and CEO | Bought | 5,000 | $1.15 | $6k | 73,419 | SEC |
| Apr 8, 2016 | Apr 11, 2016 | SOLENO THERAPEUTICS INC | President and CEO | Exercised or settledEmployee Stock Option | 58,419 | 0 | SEC | ||
| Apr 8, 2016 | Apr 11, 2016 | SOLENO THERAPEUTICS INC | President and CEO | Exercised options | 58,419 | $1.20 | $70k | 58,419 | SEC |
| Jan 10, 2016 | Jan 11, 2016 | SOLENO THERAPEUTICS INC | Officer, Director | AwardedEmployee Stock Option | 300,000 | 300,000 | SEC | ||
| Aug 12, 2015 | Aug 13, 2015 | SOLENO THERAPEUTICS INC | Officer, Director | Bought | 10,000 | $1.64 | $16k | 10,000 | SEC |
| May 15, 2015 | May 19, 2015 | SOLENO THERAPEUTICS INC | Officer, Director | AwardedEmployee Stock Option | 150,000 | 150,000 | SEC |
Page 1
Sales and notices (14)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2025 | Mar 31, 2025 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Form 4 sale | 699,095 | $47.3M | 54.8% | Unusual | SEC |
| Mar 27, 2025 | Mar 27, 2025 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Form 144 notice | 746,041 | $37.3M | Notice | SEC | |
| Jan 3, 2025 | Jan 6, 2025 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Form 4 sale | 21,091 | $966k | 2.9% | No plan | SEC |
| Oct 1, 2024 | Oct 3, 2024 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Form 4 sale | 21,633 | $1.1M | 2.9% | No plan | SEC |
| Aug 29, 2024 | Aug 30, 2024 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Form 4 sale | 115,004 | $5.5M | 13.4% | Unusual | SEC |
| Aug 6, 2024 | Aug 7, 2024 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Form 4 sale | 127,344 | $5.8M | 12.9% | Unusual | SEC |
| Jul 1, 2024 | Jul 3, 2024 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Form 4 sale | 19,256 | $800k | 12.6% | No plan | SEC |
| Apr 1, 2024 | Apr 3, 2024 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Form 4 sale | 18,980 | $785k | 11.0% | No plan | SEC |
| Jan 25, 2024 | Jan 29, 2024 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Form 4 sale | 2,527 | $122k | 1.4% | No plan | SEC |
| Dec 11, 2023 | Dec 13, 2023 | SOLENO THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 93,408 | $3.3M | 79.4% | Unusual | SEC |
| Dec 11, 2023 | Dec 11, 2023 | SOLENO THERAPEUTICS INC | CHIEF EXECUTIVE OFFICER | Form 144 notice | 93,408 | $3.4M | Notice | SEC | |
| Nov 30, 2023 | Dec 4, 2023 | SOLENO THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 27,716 | $794k | 20.4% | No plan | SEC |
| Nov 29, 2023 | Nov 30, 2023 | SOLENO THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 53,505 | $1.5M | 28.3% | Unusual | SEC |
| Jan 21, 2022 | Jan 25, 2022 | SOLENO THERAPEUTICS INC | Chief Executive Officer | Form 4 sale | 39,033 | $14k | 9.5% | Plan not stated | SEC |